/Investor DB

Alta Life Sciences

Barcelona · Seed–Late Stage · 2 people tracked

Find your way into Alta Life Sciences

1,038 people in our graph can introduce you to the Alta Life Sciences team.

Sign up to see every warm intro you have to Alta Life Sciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Alta Life Sciences team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit
Stage
Seed–Late Stage
HQ
Barcelona, ES
Founded
2016
Tracked investments
8

Team · 2 people

from curated & public directories

What they invest in

from 8 of 8 portfolio companies

Biotech ×5Healthtech ×5Medical Devices ×5AI & Machine Learning ×2Deep Tech ×2Digital Health ×2Cloud Computing ×1Data & Infrastructure ×1

HQs:Spain×3United States×1

Investments · 8 tracked

founders shown can be your intro path

By year:2021 · 22020 · 42018 · 17 dated

Accure Therapeuticsaccure.healthSeries A · May 2020 · $8M

Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases.

BiotechHealthtech

Laurent Nguyen(Chief Executive Officer, Board member)inPablo Villoslada(CSO)inRossella Medori(CMO)inPaul Bikard(CFO)in

Co-investorsAliath BioventuresAsabys PartnersKinled HoldingLifelink

Clear Labsclearlabs.cominSeries B · Oct 2018 · $21M

Clear Labs develops fully automated next-generation sequencing (NGS) platforms that process genomic data into insights for research and surveillance applications across infectious disease, food safety, and oncology.

BiotechData & InfrastructureDeep TechHealthtechMedical DevicesSan Carlos, US

Sasan Amini(Founder)inRamin Khaksar(Founder)inEdward Fan(Executive Officer)inBrodie Flanders(Executive Officer, Director)Kazutaka Ohno(Executive Officer)Farzad Naimi(Executive Officer, Director)

Co-investorsMenlo VenturesKhosla VenturesNimble VenturesAlumni VenturesCastor VenturesDentsu Ventures+14 more

Deepulldeepull.cominSeries A · Jul 2020 · $4M

Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.

Medical Devices

Co-investorsAsabys PartnersColumbus Venture PartnersKurma PartnersPanakes Partners

Inbiomotioninbiomotion.comJan 2021

InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients.

BiotechDigital HealthMedical Devices

BoardProf Rob E. Coleman(Chairman)

Co-investorsAsabys PartnersCriteria Bio VenturesYsios Capital

Mediktormediktor.cominOct 2021 · $13M

Mediktor is an AI-powered healthcare chatbot platform that enables patients to assess symptoms and receive preliminary guidance through natural language conversations.

AI & Machine LearningDigital HealthHealthtechBarcelona, ES

Oscar García-Esquirol(Co-founder / Medical Director)inCristian Pascual(Founder)inRoger Forcada(CTO)in

Co-investorsAsabys Partners

Onaona.comin𝕏Jun 2020

Ona provides cloud-based agent infrastructure that runs developer tasks in isolated environments while laptops are closed, automating workflow execution through events, schedules, and pull requests.

AI & Machine LearningCloud ComputingDeveloper Tools

Jan Koehnlein(Founder)Johannes Landgraf(Founder)Moritz Eysholdt(Founder)Sven Efftinge(Founder)

Co-investorsBright Pixel CapitalCrane Venture PartnersPebblebedPreston-Werner VenturesVertex VenturesAsabys Partners+7 more

Ona Therapeuticsona-therapeutics.comin𝕏Series A · Jun 2020 · $34M

Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma.

BiotechHealthtechMedical Devices

Co-investorsAsabys PartnersFund+KorysMérieux Equity PartnersYsios CapitalBpifrance+2 more

Peptomycpeptomyc.comin𝕏

Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials.

BiotechDeep TechHealthtechMedical DevicesBarcelona, ES

Dr. Marie-Eve Beaulieu(Co-founder)Laura Soucek(Co-founder & CSO (former CEO))in

Co-investorsAsabys PartnersAurora ScienceInvivo Capital Partners

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Alta Life Sciences made?
Alta Life Sciences has 8 tracked investments.
What stage does Alta Life Sciences invest at?
Alta Life Sciences invests at the Seed, Late Stage stages.
Where is Alta Life Sciences located?
Alta Life Sciences is headquartered in Barcelona, ES.

Co-investors · 3

Felicis Ventures

Felicis is a venture capital firm that backs early-stage founders, investing primarily at Seed and Series A across artificial intelligence, cybersecurity and defense, global resilience and energy, and health and bio.

Both backed · 1
$500K – $15M
Menlo Ventures

Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.

Both backed · 1
$1M – $20M

Firms observed investing alongside Alta Life Sciences, from public investor directories. Shared companies are the overlap with Alta Life Sciences's recorded portfolio.

Similar investors

Featured in lists